Literature DB >> 35344834

Engineering the T cell receptor for fun and profit: Uncovering complex biology, interrogating the immune system, and targeting disease.

Aaron M Rosenberg1, Brian M Baker2.   

Abstract

T cell receptors (TCRs) orchestrate cellular immunity by recognizing peptide antigens bound and presented by major histocompatibility complex (MHC) proteins. Due to the TCR's central role in immunity and tight connection with human health, there has been significant interest in modulating TCR properties through protein engineering methods. Complicating these efforts is the complexity and vast diversity of TCR-peptide/MHC interfaces, the interdependency between TCR affinity, specificity, and cross-reactivity, and the sophisticated relationships between TCR binding properties and T cell function, many aspects of which are not well understood. Here we review TCR engineering, starting with a brief historical overview followed by discussions of more recent developments, including new efforts and opportunities to engineer TCR affinity, modulate specificity, and develop novel TCR-based constructs.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35344834      PMCID: PMC9189011          DOI: 10.1016/j.sbi.2022.102358

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   7.786


  71 in total

1.  Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.

Authors:  S Hausmann; W E Biddison; K J Smith; Y H Ding; D N Garboczi; U Utz; D C Wiley; K W Wucherpfennig
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibition.

Authors:  Bruno Laugel; Jonathan M Boulter; Nikolai Lissin; Annelise Vuidepot; Yi Li; Emma Gostick; Laura E Crotty; Daniel C Douek; Joris Hemelaar; David A Price; Bent K Jakobsen; Andrew K Sewell
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

3.  Alanine scanning mutagenesis of an alphabeta T cell receptor: mapping the energy of antigen recognition.

Authors:  T C Manning; C J Schlueter; T C Brodnicki; E A Parke; J A Speir; K C Garcia; L Teyton; I A Wilson; D M Kranz
Journal:  Immunity       Date:  1998-04       Impact factor: 31.745

4.  Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.

Authors:  B Hemmer; M Vergelli; B Gran; N Ling; P Conlon; C Pinilla; R Houghten; H F McFarland; R Martin
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

Review 5.  T cell antigen discovery.

Authors:  Alok V Joglekar; Guideng Li
Journal:  Nat Methods       Date:  2020-07-06       Impact factor: 28.547

6.  Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.

Authors:  Paul Nathan; Jessica C Hassel; Piotr Rutkowski; Jean-Francois Baurain; Marcus O Butler; Max Schlaak; Ryan J Sullivan; Sebastian Ochsenreither; Reinhard Dummer; John M Kirkwood; Anthony M Joshua; Joseph J Sacco; Alexander N Shoushtari; Marlana Orloff; Josep M Piulats; Mohammed Milhem; April K S Salama; Brendan Curti; Lev Demidov; Lauris Gastaud; Cornelia Mauch; Melinda Yushak; Richard D Carvajal; Omid Hamid; Shaad E Abdullah; Chris Holland; Howard Goodall; Sophie Piperno-Neumann
Journal:  N Engl J Med       Date:  2021-09-23       Impact factor: 176.079

7.  Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

Authors:  Laura A Johnson; Richard A Morgan; Mark E Dudley; Lydie Cassard; James C Yang; Marybeth S Hughes; Udai S Kammula; Richard E Royal; Richard M Sherry; John R Wunderlich; Chyi-Chia R Lee; Nicholas P Restifo; Susan L Schwarz; Alexandria P Cogdill; Rachel J Bishop; Hung Kim; Carmen C Brewer; Susan F Rudy; Carter VanWaes; Jeremy L Davis; Aarti Mathur; Robert T Ripley; Debbie A Nathan; Carolyn M Laurencot; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-18       Impact factor: 22.113

8.  High-throughput modeling and scoring of TCR-pMHC complexes to predict cross-reactive peptides.

Authors:  Tyler Borrman; Brian G Pierce; Thom Vreven; Brian M Baker; Zhiping Weng
Journal:  Bioinformatics       Date:  2020-12-23       Impact factor: 6.937

Review 9.  The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics.

Authors:  Timothy P Riley; Brian M Baker
Journal:  Semin Cell Dev Biol       Date:  2018-12       Impact factor: 7.499

10.  Domain-swapped T cell receptors improve the safety of TCR gene therapy.

Authors:  Michael T Bethune; Marvin H Gee; Mario Bunse; Mark S Lee; Eric H Gschweng; Meghana S Pagadala; Jing Zhou; Donghui Cheng; James R Heath; Donald B Kohn; Michael S Kuhns; Wolfgang Uckert; David Baltimore
Journal:  Elife       Date:  2016-11-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.